![](https://investorshub.advfn.com/uicon/593644.png?cb=1486745604)
Wednesday, October 10, 2018 7:26:37 PM
"
OWCP has a dissolving tablet to target Fibromyalgia and chronic pain. The proprietary technology is sublingual and will be used to target non-smokers for cannabis therapeutics related to the above mentioned diseases along with PTSD. The tablet can absorb directly into the bloodstream and has shown first liver bypass as well."
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM